Tag: Wilmot Cancer Center
Medical Center researchers have shown for the first time how cancer-causing mutations control and alter the way cancer cells biosynthesize and replicate.
A study from the Wilmot Cancer Institute is believed to be the first to examine how leukemia stem cells change over time, and the first to look for several known gene biomarkers simultaneously.
Ed Foster, a physician from Elmira, is the first person in upstate New York to receive an innovative new therapy at Wilmot Cancer Institute that involves engineering a patient’s own immune cells to attack cancer.
A Wilmot Cancer Institute investigator discovered a gene that’s required for the initiation of melanoma and the growth of disseminated melanoma cancer cells in the lungs.
The grant from The National Cancer Institute awarded will fund continued study of a gene network that controls cancer progression, with a focus on pancreatic cancer.
The Wilmot family and the James P. Wilmot foundation are giving $4 million to support cancer research. The announcement was made at the Discovery Ball Saturday night at the Rochester Riverside Convention Center. The money will be part of a $30 million dollar research-focused campaign at UR Medicine.